Mostafa Farzin1,2, Michael Molls3, Sabrina Astner4, Ina-Christine Rondak5, Markus Oechsner6. 1. Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675, Munich, Germany. mfarzin1355@yahoo.com. 2. Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Science, Tehran, Iran. mfarzin1355@yahoo.com. 3. Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675, Munich, Germany. michael.molls@lrz.tum.de. 4. Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675, Munich, Germany. Sabrina.Astner@gmx.de. 5. Institut für Medizinische Statistik und Epidemiologie, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. ina.rondak@tum.de. 6. Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Strasse 22, 81675, Munich, Germany. markus.oechsner@lrz.tu-muenchen.de.
Abstract
BACKGROUND: In 20 patients with high-grade gliomas, we compared two methods of planning for volumetric-modulated arc therapy (VMAT): simultaneous integrated boost (SIB) vs. sequential boost (SEB). The investigation focused on the analysis of dose distributions in the target volumes and the organs at risk (OARs). METHOD: After contouring the target volumes [planning target volumes (PTVs) and boost volumes (BVs)] and OARs, SIB planning and SEB planning were performed. The SEB method consisted of two plans: in the first plan the PTV received 50 Gy in 25 fractions with a 2-Gy dose per fraction. In the second plan the BV received 10 Gy in 5 fractions with a dose per fraction of 2 Gy. The doses of both plans were summed up to show the total doses delivered. In the SIB method the PTV received 54 Gy in 30 fractions with a dose per fraction of 1.8 Gy, while the BV received 60 Gy in the same fraction number but with a dose per fraction of 2 Gy. RESULTS: All of the OARs showed higher doses (Dmax and Dmean) in the SEB method when compared with the SIB technique. The differences between the two methods were statistically significant in almost all of the OARs. Analysing the total doses of the target volumes we found dose distributions with similar homogeneities and comparable total doses. CONCLUSION: Our analysis shows that the SIB method offers advantages over the SEB method in terms of sparing OARs.
BACKGROUND: In 20 patients with high-grade gliomas, we compared two methods of planning for volumetric-modulated arc therapy (VMAT): simultaneous integrated boost (SIB) vs. sequential boost (SEB). The investigation focused on the analysis of dose distributions in the target volumes and the organs at risk (OARs). METHOD: After contouring the target volumes [planning target volumes (PTVs) and boost volumes (BVs)] and OARs, SIB planning and SEB planning were performed. The SEB method consisted of two plans: in the first plan the PTV received 50 Gy in 25 fractions with a 2-Gy dose per fraction. In the second plan the BV received 10 Gy in 5 fractions with a dose per fraction of 2 Gy. The doses of both plans were summed up to show the total doses delivered. In the SIB method the PTV received 54 Gy in 30 fractions with a dose per fraction of 1.8 Gy, while the BV received 60 Gy in the same fraction number but with a dose per fraction of 2 Gy. RESULTS: All of the OARs showed higher doses (Dmax and Dmean) in the SEB method when compared with the SIB technique. The differences between the two methods were statistically significant in almost all of the OARs. Analysing the total doses of the target volumes we found dose distributions with similar homogeneities and comparable total doses. CONCLUSION: Our analysis shows that the SIB method offers advantages over the SEB method in terms of sparing OARs.
Authors: Anne W M Lee; Dora L W Kwong; Sing Fai Leung; Stewart Y Tung; Wai Man Sze; Jonathan S T Sham; Peter M L Teo; To Wai Leung; Po Man Wu; Rick Chappell; Lester J Peters; John F Fowler Journal: Int J Radiat Oncol Biol Phys Date: 2002-05-01 Impact factor: 7.038
Authors: Joseph M Baisden; Jason Sheehan; Andrew G Reish; Alyson F McIntosh; Ke Sheng; Paul W Read; Stanley H Benedict; James M Larner Journal: Neurol Res Date: 2011-10 Impact factor: 2.448
Authors: Daniel F Fleischmann; Marcus Unterrainer; Stefanie Corradini; Maya Rottler; Stefan Förster; Christian la Fougère; Timo Siepmann; Markus Schwaiger; Peter Bartenstein; Claus Belka; Nathalie L Albert; Maximilian Niyazi Journal: PLoS One Date: 2019-07-24 Impact factor: 3.240
Authors: Chris Staudinger; Valeria Meier; Katrin Beckmann; Maximilian Körner; Carla Rohrer Bley Journal: J Vet Intern Med Date: 2022-06-30 Impact factor: 3.175